SMPL

AI Memo

Simply Good Foods

As of 2026-10-28/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-28 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Fiscal Q1 2027 tests the turnaround • 2027-01-31

Base target: $10 / p=45% prob

Biggest risk

The modest Q4 beat is outweighed by management's FY2027 outlook for a 13%–17% sales decline and 9%–14% adjusted-EBITDA decline. Atkins and OWYN weakness, distribution pressure and pricing-related volume risk leave the turnaround unproven. No reliable post-print analyst target or estimate revisions were established. [#SEC-8K-2026-10-27] Company earnings release

Invalidation

Break below $7 or thesis failure.

What would change my mind?

Q4 adjusted EPS of $0.44 exceeded the $0.42 consensus reported by Investing.com, and revenue of $333.3 million exceeded its $327.9 million estimate. FY2026 operating cash flow was about $181 million, with 0.9x net debt to adjusted EBITDA. A successful pricing and marketing reset could make the low valuation compelling. Earnings comparison [#SEC-8K-2026-10-27] Company earnings release

Research note

Recommendation

—

Confidence

medium

As of

2026-10-28

Base target

$10

p=45%

Bull target

$13

p=25%

Bear target

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Atkins and OWYN retail-takeaway stabilization
Gross-margin recovery versus brand reinvestment
Q4 adjusted EPS of $0.44 exceeded the $0.42 consensus reported by Investing.com, and revenue of $333.3 million exceeded its $327.9 million estimate.

BearKey bullets

Atkins and OWYN retail-takeaway declines and velocity-related distribution pressure could persist despite marketing investment.
[#SEC-8K-2026-10-27] Company earnings release
FY2026 included $331 million of non-cash goodwill and brand-asset impairments, reflecting weaker performance and revised revenue projections.

WatchKey bullets

Fiscal Q1 2027 tests the turnaround

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $10 (p=45%)

Target spread vs base: +30% / -28%

Scenario probabilities

Bull Target: $13 (p=25%)Base Target: $10 (p=45%)Bear Target: $7 (p=30%)

Commentary

The October 27 adjusted-EPS and revenue beat was met by a decline from the prior $10.09 close to the packet's $9.75 adjusted-close anchor, approximately 3.4%; weak FY2027 guidance is a plausible interpretation, not an isolated causal proof. Prior close Initial earnings coverage Post-print analyst revisions were not verified. Social, options, short-interest and employee measures are unavailable; zeros above are placeholders, not neutral observations. The stored earnings-document row concerns Hershey, not SMPL, and was excluded.

As of 2026-10-28 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Atkins and OWYN retail-takeaway stabilization
Gross-margin recovery versus brand reinvestment

Scenarios

Bull Target (Scenario probability)

$13 / p=25% prob

Base Target (Scenario probability)

$10 / p=45% prob

Bear Target (Scenario probability)

$7 / p=30% prob

Analysis 2026-10-28 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.35

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2027-01-31
Fiscal Q1 2027 tests the turnaround
After Q4 sales fell 9.7%, management expects Q1 sales to decline 19%–22% and adjusted EBITDA to decline 28%–33%. The next report will test whether pricing adds further volume pressure. Reporting date is estimated, not announced. [#SEC-8K-2026-10-27] Company earnings release
Prob 45.00% • Move 10.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

Atkins and OWYN retail-takeaway stabilization
2027-01-31
Q4 retail takeaway fell approximately 23% for Atkins and 7% for OWYN; management also cited softer retail takeaway and velocity-related distribution pressure. Slower declines would support the reset, while further deterioration would weaken it. [#SEC-8K-2026-10-27] Company earnings release
Prob 40% • Move 8% • Priced-in 40%

Long-term Catalysts

Months to a year

Gross-margin recovery versus brand reinvestment
2027-08-31
Management guides to a 250–300-basis-point FY2027 gross-margin increase but also expects sales to fall 13%–17% and adjusted EBITDA to fall 9%–14% as it reinvests behind brands. The test is whether recovered margin ultimately produces durable earnings growth. Fiscal-year-end date is estimated. [#SEC-8K-2026-10-27] Company earnings release
Prob 40% • Move 20% • Priced-in 35%

Risks

Atkins and OWYN retail-takeaway declines and velocity-related distribution pressure could persist despite marketing investment. [#SEC-8K-2026-10-27] Company earnings release
FY2026 included $331 million of non-cash goodwill and brand-asset impairments, reflecting weaker performance and revised revenue projections. Company earnings release
Management guides to a materially deeper FY2027 sales decline, including a 19%–22% decline in Q1. [#SEC-8K-2026-10-27] Company earnings release
Pricing could further reduce volume, while margin recovery may be absorbed by brand spending rather than lift EBITDA. [#SEC-8K-2026-10-27] Company earnings release

Peers

Symbol	Summary
BRBR	Closest listed product comparator through protein shakes and powders, though its brand mix differs from SMPL's Quest, Atkins and OWYN portfolio. BellRing SEC filing
LWAY	Adjacent health-oriented beverage comparator, but kefir is not a direct protein-snacking match; unsuitable for a tight valuation multiple. Lifeway investor relations

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-28

Loading AI feed…

Symbol

Summary

BRBR

Closest listed product comparator through protein shakes and powders, though its brand mix differs from SMPL's Quest, Atkins and OWYN portfolio. BellRing SEC filing

LWAY

Adjacent health-oriented beverage comparator, but kefir is not a direct protein-snacking match; unsuitable for a tight valuation multiple. Lifeway investor relations